Written by Clarissa Farnell
Learn what manufacturing changes trigger FDA re-evaluation for generic drugs. Understand PAS vs. CBE classifications, review timelines, and strategies to minimize regulatory delays.
Written by Clarissa Farnell
Explore the major FDA generic approval changes from 2023-2025, including the ANDA Prioritization Pilot Program and its impact on U.S. drug manufacturing and pricing.